News

Furthermore, investors need to believe Elanco will rebound from China’s lockdown in the last quarter. Elanco Animal Health Q2 Earnings. Elanco posted non-GAAP earnings per share of 36 cents.
We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...
Earnings Call Insights: Elanco Animal Health Incorporated (ELAN) Q1 2025 Management View CEO Jeffrey Simmons highlighted that Elanco exceeded Q1 guidance across revenue, adjusted EBITDA, and ...
Elanco has fallen short in the fast-growing, ... China, is on the verge of entering a new hog cycle. Total hog inventory reached a 5-year low, ...
GREENFIELD, IN / ACCESS Newswire / June 26, 2025 / Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced the release of its 2024 Impact Report, showcasing its efforts to enhance animal care, ...
Elanco is only now close to rolling out Zenrelia and Credelio Quattro, ... China, is on the verge of entering a new hog cycle. Total hog inventory reached a 5-year low, ...
Elanco Animal Health, Inc. (NYSE:ELAN) Q4 2020 Earnings Conference Call February 24, ... However, both species remain important growth drivers for Elanco over time. Moving to China swine, ...
Elanco Animal Health Incorporated (NYSE: ELAN) today announced the appointment of Robert VanHimbergen as Executive Vice President and Chief Financial Officer, effective July 7, 2025. VanHimbergen ...
Elanco Animal Health Incorporated (NYSE: ELAN) today reported its financial results for the fourth quarter and full year 2021, ... partially offset by pressure in the China swine business.
Elanco’s falling stock price—which was about $11 this week—indicates that many investors are not ... from COVID lockdowns in China and a supply-chain disruption to a global economic slowdown ...
Elanco Animal Health Inc. (ELAN-1.06%) Q2 2022 Earnings Call Aug 08, 2022, 8:00 a.m. ET Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Hello, and ...
Elanco Animal Health Inc.’s stock was headed for an 18-month high on Monday after the company said it has agreed to sell its aqua business to Merck Animal Health for $1.3 billion in cash, ...